Skip to main content
iMed Technologies
← Back to list
Conference

Our CEO Kenichi Kono to speak at an event hosted by LINK-J

Kenichi Kono, physician and Representative Director and CEO of iMed Technologies, Inc. (headquartered in Shibuya-ku, Tokyo), which develops surgical support AI for ischemic stroke and subarachnoid hemorrhage, will give a presentation as a guest speaker at an event hosted by the Life Science Innovation Network Japan (LINK-J) on Monday, August 26, 2019.

Kenichi Kono, physician and Representative Director and CEO of iMed Technologies, Inc. (headquartered in Shibuya-ku, Tokyo), which develops surgical support AI for ischemic stroke and subarachnoid hemorrhage, will give a presentation as a guest speaker at the event “L x T bridge: LS Management and Strategy x AI — Innovation Through Human Connections,” hosted by the Life Science Innovation Network Japan (LINK-J), on Monday, August 26, 2019.

See the following link for event details. https://www.link-j.org/event/post-1649.html

■iMed Technologies, Inc. Company Profile Company name: iMed Technologies, Inc. Address: 5F Eclat Shibuya, 3-6-2 Shibuya, Shibuya-ku, Tokyo Founded: April 1, 2019 Business: Development of surgical support AI for ischemic stroke and subarachnoid hemorrhage Representatives: Representative Director and CEO, physician Kenichi Kono Representative Director and COO, Motohisa Kaneko

■Inquiries regarding this release Email: info@imed-tech.co.jp